We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis Faces Trial Or Settlement After Judge Rules in Favor of Whistleblower Suit
Novartis Faces Trial Or Settlement After Judge Rules in Favor of Whistleblower Suit
Novartis finds itself in a tough spot after a federal judge refused the company’s request to toss a whistleblower lawsuit that could cost the Swiss-based pharma giant hundreds of millions of dollars.